Prof. Dr. med. Patrick Meybohm will present the first safety and efficacy results from the REMOVE study evaluating CATUVAB ®, a medical device that aggregates tumor cells and lymphocytes and removes ...
HENNIGSDORF, GERMANY / ACCESSWIRE / April 22, 2024 / Lindis Blood Care, a company aiming to set a new standard for blood management during cancer surgeries with its medical device CATUVAB ®, announced ...
Presenter: Prof. Dr. med. Patrick Meybohm, Head of the Department of Anesthesiology, Intensive Care, Emergency and Pain Medicine at the University Hospital Würzburg. Time: April 19, 2024 - 12:00-1:00 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback